E
Actavia Life Sciences, Inc. RASP
$0.004 -$0.0285-87.69%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

03/31/2024 12/31/2023
Revenue -- --
Total Other Revenue -- --
Total Revenue -- --
Cost of Revenue -- --
Gross Profit -- --
SG&A Expenses -43.31% 204.30%
Depreciation & Amortization -- --
Other Operating Expenses -- --
Total Operating Expenses -42.74% 155.53%
Operating Income 42.74% -155.53%
Income Before Tax 35.30% -153.17%
Income Tax Expenses -- --
Earnings from Continuing Operations 35.30% -153.17%
Earnings from Discontinued Operations -- --
Extraordinary Item & Accounting Change -- --
Minority Interest in Earnings -- --
Net Income 35.30% -153.17%
EBIT 42.74% -155.53%
EBITDA -- --
EPS Basic 50.00% -100.00%
Normalized Basic EPS 0.00% --
EPS Diluted 50.00% 88.89%
Normalized Diluted EPS 0.00% --
Average Basic Shares Outstanding 0.00% 0.20%
Average Diluted Shares Outstanding 0.00% 0.20%
Dividend Per Share -- --
Payout Ratio -- --
Weiss Ratings